EP4176877

Aðferðir til að efla og/eða stöðga hjartavirkni í sjúklingum með Fabry-sjúkdóm

  • Status:
    EP einkaleyfi í gildi á Íslandi
  • EP appl. date:
    28.8.2018
  • EP published:
    4.12.2024
  • EP application number:
    22194251.9
  • Max expiry date:
    27.8.2038
  • Expiry date:
    27.8.2026
  • Next due date:
    31.8.2026
  • Title in English:
    METHODS OF ENHANCING AND/OR STABILIZING CARDIAC FUNCTION IN PATIENTS WITH FABRY DISEASE
  • Language of the patent:
    English

Timeline

Today
28.8.2018EP application
4.12.2024EP Publication
24.2.2025Translation submitted
15.3.2025Registration published
27.8.2026Expires

Owner

  • Name:
    Amicus Therapeutics, Inc.
  • Address:
    3675 Market Street, Philadelphia, PA 19104, US

Inventor

  • Name:
    CASTELLI, Jeff
  • Address:
    Philadelphia, 19104, US
  • Name:
    BARTH, Jay
  • Address:
    Philadelphia, 19104, US
  • Name:
    SKUBAN, Nina
  • Address:
    Philadelphia, 19104, US

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113, Reykjavík,

Priority

  • Number:
    201762550984 P
  • Date:
    28.8.2017
  • Country:
    US

Classification

  • Categories:
    A61K 31/445, A61P 9/04, A61P 43/00

Annual fees

Number

Paid

Expires

Payer

Number: 8

Paid: 11.8.2025

Expires: 27.8.2026

Payer: Árnason Faktor ehf.

Upload documents